Evolution of severe (transfusion‐dependent) anaemia in myelodysplastic syndromes with 5q deletion is characterized by a macrophage‐associated failure of the eythropoietic niche
Authors:
Open Access
- 1 April 2022
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 198 (1) , 114-130
Abstract
Summary: Evolution of erythrocyte transfusion‐dependent (RBC‐TD) anaemia associated with haploinsufficiency of the ribosomal protein subunit S14 gene (RPS14) is a characteristic complication of myelodysplastic syndromes (MDS) with del(5q) [MDS.del(5q)]. Evaluating 39 patients with MDS.del(5q), RPS14‐dependent alterations of normoblasts, pro‐erythroblasts, or CD34+CD71+ precursors. Ninety‐three percent of anaemia progression and 70% of the absolute decline in peripheral blood Hb value were attributable to disappearance of erythroblastic islands (Ery‐Is). Ery‐Is loss occurred independently of blast excess, TP53 mutation, additional chromosome aberrations and RPS14‐dependent alterations of normoblasts and pro‐erythroblasts. It was associated with RPS14‐dependent intrinsic (S100A8+) and extrinsic [tumour necrosis factor α (TNF‐α)‐overproduction] alterations of (CD169+) marrow macrophages (p < 0.00005). In a mouse model of RPS14 haploinsufficiency, Ery‐Is disappeared to a similar degree: approximately 70% of Ery‐Is loss was related to RPS14‐dependent S100A8 overexpression of marrow macrophages, less than 20% to that of CD71highTer119− immature precursors, and less than 5% to S100A8/p53 overexpression of normoblasts or pro‐erythroblasts. Marked Ery‐Is loss predicted reduced efficacy (erythrocyte transfusion independence) of lenalidomide therapy (p = 0.0006). Thus, erythroid hypoplasia, a characteristic complication of MDS.del(5q), seems to result primarily from a macrophage‐associated failure of the erythropoietic niche markedly reducing the productive capacity of erythropoiesis as the leading factor in anaemia progression and evolution of RBC‐TD in MDS.del(5q).Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (DFG‐24192914, DFG1188/3‐1)
- Deutsche Krebshilfe (111750)
- Edward P. Evans Foundation
This publication has 58 references indexed in Scilit:
- The Role of Haploinsufficiency of rps14 and p53 Activation in the Molecular Pathogenesis of the 5q- SyndromePediatric Reports, 2011
- Non–Diamond Blackfan Anemia Disorders of Ribosome Function: Shwachman Diamond Syndrome and 5q- SyndromeSeminars in Hematology, 2011
- A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q– syndromeNature Medicine, 2009
- Unimpaired terminal erythroid differentiation and preserved enucleation capacity in myelodysplastic 5q(del) clones: a single cell studyHaematologica, 2009
- Erythroblastic islands: niches for erythropoiesisBlood, 2008
- Identification of RPS14 as a 5q- syndrome gene by RNA interference screenNature, 2008
- New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patientsBlood, 2007
- Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromesLeukemia, 2007
- Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic SyndromesJournal of Clinical Oncology, 2007
- Approximate Inference in Generalized Linear Mixed ModelsJournal of the American Statistical Association, 1993